Home Categories Send inquiry

Europe style for trans-1 4-Dibromo-2-butene - Adenosine 5′-Monophosphate (5′-AMP) CAS 61-19-8 High Purity – Ruifu

Manufacturer Supply Nucleotide Intermediates with High Purity and Stable Quality
Citicoline CAS: 987-78-0
Cytidine 5′-Monophosphate, Free Acid (5′-CMP) CAS: 63-37-6
Adenosine 5′-Monophosphate Disodium Salt Hexahydrate (5′-AMP-Na2) CAS: 4578-31-8
Adenosine 5′-Monophosphate Sodium Salt CAS: 13474-03-8
Adenosine 5′-Monophosphate,Free Acid (5′-AMP) CAS: 61-19-8
Uridine 5′-Monophosphate Disodium Salt Hydrate (5′-UMP 2Na Hydrate) CAS: 3387-36-8
Cytidine 5′-Monophosphate Disodium Salt (5′-CMP 2Na) CAS: 6757-06-8

Chemical Name Adenosine 5'-Monophosphate, Free Acid
Synonyms 5'-AMP; 5'-Adenylic Acid
CAS Number 61-19-8
CAT Number RF-PI200
Stock Status In Stock
Molecular Formula C10H14N5O7P
Molecular Weight 347.22 
Brand Ruifu Chemical
Item Specifications
Appearance White or Off-White Powder
Identification A/A A250 / A260 =0.79~0.89
A280 / A260 =0.17~0.27
Loss on Drying ≤8.0%
Purity ≥98.0%
Assay ≥90.0%
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates; Food Additives

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Adenosine 5'-monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine 5'-monophosphate is an ester of phosphoric acid with the nucleoside adenosine. It's a useful ligand determinant that facilitate the binding of APS reductase inhibitors and activates adenosine receptor agonists. 5'-AMP is an activator of a class of protein kinases known as AMP-activated protein kinase, an activator of phosphorylase b in the polymerization reaction for the synthesis of branched polysaccharides, a reagent in the synthesis of adenosine-5'-phosphoimidazolide, an inhibitor of endogenous NMN adenylyltransferase (NMNAT) activity that converts NMN to NAD+.